awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q58800689-67120708-2202-4F70-AB26-57E64E7EC38B
Q58800689-67120708-2202-4F70-AB26-57E64E7EC38B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58800689-67120708-2202-4F70-AB26-57E64E7EC38B
Cost-effectiveness analysis of FOLFOX4 and sorafenib for the treatment of advanced hepatocellular carcinoma in China
P2860
Q58800689-67120708-2202-4F70-AB26-57E64E7EC38B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58800689-67120708-2202-4F70-AB26-57E64E7EC38B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d34b390fc4dfa8870fb93b383ae508a8375ee277
P2860
Economic evaluation of sorafenib in unresectable hepatocellular carcinoma.